BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burr JM, Botello-Pinzon P, Takwoingi Y, Hernández R, Vazquez-Montes M, Elders A, Asaoka R, Banister K, van der Schoot J, Fraser C. Surveillance for ocular hypertension: an evidence synthesis and economic evaluation. Health Technol Assess. 2012;16:1-271, iii-iv. [PMID: 22687263 DOI: 10.3310/hta16290] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Roberts SLE, Healey A, Sevdalis N. Use of health economic evaluation in the implementation and improvement science fields-a systematic literature review. Implement Sci 2019;14:72. [PMID: 31307489 DOI: 10.1186/s13012-019-0901-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 15.0] [Reference Citation Analysis]
2 Quérat L, Chen E. Monitoring daily intraocular pressure fluctuations with self-tonometry in healthy subjects. Acta Ophthalmol 2017;95:525-9. [PMID: 28296082 DOI: 10.1111/aos.13389] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
3 Harper RA, Gunn PJG, Spry PGD, Fenerty CH, Lawrenson JG. Care pathways for glaucoma detection and monitoring in the UK. Eye (Lond) 2020;34:89-102. [PMID: 31700149 DOI: 10.1038/s41433-019-0667-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
4 Thouin A, Griffiths PG, Hudson G, Chinnery PF, Yu-Wai-Man P. Raised intraocular pressure as a potential risk factor for visual loss in Leber Hereditary Optic Neuropathy. PLoS One 2013;8:e63446. [PMID: 23667621 DOI: 10.1371/journal.pone.0063446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
5 Azuara-Blanco A, Banister K, Boachie C, McMeekin P, Gray J, Burr J, Bourne R, Garway-Heath D, Batterbury M, Hernández R, McPherson G, Ramsay C, Cook J. Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study). Health Technol Assess 2016;20:1-168. [PMID: 26822760 DOI: 10.3310/hta20080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
6 Tuulonen A. Challenges of glaucoma care - high volume, high quality, low cost: A cta O phthalmologica 2012. Acta Ophthalmologica 2013;91:3-5. [DOI: 10.1111/aos.12088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Takwoingi Y, Botello AP, Burr JM, Azuara-Blanco A, Garway-Heath DF, Lemij HG, Sanders R, King AJ, Deeks JJ; Surveillance for Ocular Hypertension Study Group. External validation of the OHTS-EGPS model for predicting the 5-year risk of open-angle glaucoma in ocular hypertensives. Br J Ophthalmol 2014;98:309-14. [PMID: 24357494 DOI: 10.1136/bjophthalmol-2013-303622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
8 Morriss R. Mandatory implementation of NICE Guidelines for the care of bipolar disorder and other conditions in England and Wales. BMC Med 2015;13:246. [PMID: 26420497 DOI: 10.1186/s12916-015-0464-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Hagman J. Comparison of Resource Utilization in the Treatment of Open-Angle Glaucoma between Two Cities in Finland: Is More Better? Acta Ophthalmologica 2013;91:1-47. [DOI: 10.1111/aos.12141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
10 King AJ, Fernie G, Azuara-Blanco A, Burr JM, Garway-Heath T, Sparrow JM, Vale L, Hudson J, MacLennan G, McDonald A, Barton K, Norrie J. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol. Br J Ophthalmol 2018;102:922-8. [PMID: 29074496 DOI: 10.1136/bjophthalmol-2017-310902] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
11 Kutzscher AE, Kumar RS, Ramgopal B, Rackenchath MV, Sathi Devi, Nagaraj S, Moe CA, Fry DM, Stamper RL, Keenan JD. Reproducibility of 5 Methods of Ocular Tonometry. Ophthalmology Glaucoma 2019;2:429-34. [DOI: 10.1016/j.ogla.2019.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Hernández R, Burr J, Vale L, Azuara-blanco A, Cook J, Banister K, Tuulonen A, Ryan M. Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective. Br J Ophthalmol 2016;100:1263-8. [DOI: 10.1136/bjophthalmol-2015-306757] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
13 Corro Ramos I, Hoogendoorn M, Rutten-van Mölken MPMH. How to Address Uncertainty in Health Economic Discrete-Event Simulation Models: An Illustration for Chronic Obstructive Pulmonary Disease. Med Decis Making 2020;40:619-32. [PMID: 32608322 DOI: 10.1177/0272989X20932145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 van Gestel A, Schouten JS, Beckers HJ, Severens JL, Hendrikse F, Webers CA. The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension. Acta Ophthalmol 2014;92:513-23. [PMID: 24330516 DOI: 10.1111/aos.12328] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
15 Goudie C, Pronin S, Court H, Pooley J, Tatham AJ. A national survey of the use of pachymeters by optometrists in Scotland: experience, views and barriers to use. Ophthalmic Physiol Opt 2017;37:177-83. [DOI: 10.1111/opo.12352] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kotecha A, Brookes J, Foster PJ. A technician-delivered 'virtual clinic' for triaging low-risk glaucoma referrals. Eye (Lond) 2017;31:899-905. [PMID: 28211881 DOI: 10.1038/eye.2017.9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
17 Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, Wilson EC, MacLennan G, Stallard N, Rothwell JC, Bland M, Brown L, Ramsay CR, Cook A, Armstrong D, Altman D, Vale LD. Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop. Health Technol Assess 2019;23:1-88. [PMID: 31661431 DOI: 10.3310/hta23600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
18 Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Morris S, Buszewicz M. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT. Health Technol Assess 2019;23:1-102. [PMID: 31264958 DOI: 10.3310/hta23310] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
19 Che Hamzah J, Daka Q, Azuara-Blanco A. Home monitoring for glaucoma. Eye (Lond) 2020;34:155-60. [PMID: 31772381 DOI: 10.1038/s41433-019-0669-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]